Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001033427-22-000003
Filing Date
2022-01-18
Accepted
2022-01-18 15:45:33
Documents
1
Group Members
DAVID L. COHENHAROLD J. LEVY

Document Format Files

Seq Description Document Type Size
1 axsome13ga112312021.htm SC 13G/A 47325
  Complete submission text file 0001033427-22-000003.txt   48855
Mailing Address 276 POST ROAD WEST WESTPORT CT 06880-4704
Business Address 276 POST ROAD WEST WESTPORT CT 06880-4704 2033417800
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by) CIK: 0001033427 (see all company filings)

EIN.: 061439577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Subject) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89198 | Film No.: 22535103
SIC: 2834 Pharmaceutical Preparations